Antiaging Quantum Living annual ebitda
2023
2024
2025
2026
Antiaging Quantum Living's calculated EBITDA was −$700,609 for fiscal 2026.
View full Antiaging Quantum Living company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | −$700,609 | −$54,921 | — |
| 2025 | 2025-03-31 | −$645,688 | −$239,657 | — |
| 2024 | 2024-03-31 | −$406,031 | −$369,715 | — |
| 2023 | 2023-03-31 | −$36,316 | — | — |
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | −$312,785 | −$210,364 | — |
| Q4 2026 | 2026-03-31 | −$362,635 | −$219,282 | — |
| Q3 2026 | 2025-12-31 | −$228,333 | −$65,778 | — |
| Q2 2026 | 2025-09-30 | −$7,220 | $139,084 | — |
| Q1 2026 | 2025-06-30 | −$102,421 | $91,055 | — |
| Q4 2025 | 2025-03-31 | −$143,353 | $111,716 | — |
| Q3 2025 | 2024-12-31 | −$162,555 | −$65,541 | — |
| Q2 2025 | 2024-09-30 | −$146,304 | −$122,005 | — |
| Q1 2025 | 2024-06-30 | −$193,476 | −$163,827 | — |
| Q4 2024 | 2024-03-31 | −$255,069 | — | — |
| Q3 2024 | 2023-12-31 | −$97,014 | — | — |
| Q2 2024 | 2023-09-30 | −$24,299 | — | — |
| Q1 2024 | 2023-06-30 | −$29,649 | — | — |
Across the available reported history, Antiaging Quantum Living's ebitda decreased from −$645,688 to −$700,609, a change of −$54,921. The latest reported quarter, Q1 2027, shows −$312,785.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Antiaging Quantum Living filings at SEC.gov ↗